ArticleScientific reports2026
PEAO: a bio-inspired parallel optimizer with a multi-strategy communication mechanism for breast cancer diagnosis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Breast cancer remains a leading cause of mortality among women globally. Early diagnosis and precise classification are essential for treatment and improving survival rates. This research introduces a novel algorithm: the Parallel Enzyme Action Optimizer (PEAO). PEAO introduces three key innovations: a parallel strategy to enhance global exploration, a multi-strategy communication mechanism (optimal replacement, optimal mean replacement, and circular optimal replacement) to improve information exchange, and the Lévy flight strategy to avoid local optima. The proposed algorithm was applied to optimize the hyperparameters of a BiLSTM network for breast cancer diagnosis. Experimental results on the Breast Cancer Wisconsin Diagnostic (BCWD) and Wisconsin Breast Cancer (WBC) datasets demonstrate that the PEAO-BiLSTM model significantly improves classification accuracy, precision, recall, and F1-score compared with recent meta-heuristic algorithms and other hyperparameter optimization methods. These results confirm that the proposed approach provides a robust and reliable diagnostic framework, contributing to the development of intelligent, data-driven systems for clinical decision support in breast cancer diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.